In CML, Cby1 downmodulation complements BCR-ABL1-dependent events promoting beta catenin stabilization and nuclear import which provide LSC an advantage over the normal counterpart (Figure 6). The gene discussed is CTNNB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.